Cargando…

Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer

Purpose: We aim to evaluate the robustness of multi-field IMRT and VMAT plans to target motion for left-sided BC radiotherapy. Methods: The 7-field hybrid IMRT (7F-H-IMRT) and 2-arc VMAT (2A-VMAT) plans were generated for ten left-sided BC patients. Shifts of 3 mm, 5 mm, and 10 mm in six directions...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Zhen, Zeng, Qi, Kang, Kailian, Xu, Meiling, Xiang, Xiaoyong, Liu, Chenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028731/
https://www.ncbi.nlm.nih.gov/pubmed/35447691
http://dx.doi.org/10.3390/bioengineering9040131
_version_ 1784691695783247872
author Ding, Zhen
Zeng, Qi
Kang, Kailian
Xu, Meiling
Xiang, Xiaoyong
Liu, Chenbin
author_facet Ding, Zhen
Zeng, Qi
Kang, Kailian
Xu, Meiling
Xiang, Xiaoyong
Liu, Chenbin
author_sort Ding, Zhen
collection PubMed
description Purpose: We aim to evaluate the robustness of multi-field IMRT and VMAT plans to target motion for left-sided BC radiotherapy. Methods: The 7-field hybrid IMRT (7F-H-IMRT) and 2-arc VMAT (2A-VMAT) plans were generated for ten left-sided BC patients. Shifts of 3 mm, 5 mm, and 10 mm in six directions were introduced and the perturbed dose distributions were recalculated. The dose differences (∆D) of the original plan and perturbed plan corresponded to the plan robustness for the structure. Results: Higher ∆D(98%), ∆D(95%), and ∆D(mean) of CTV were observed in 2A-VMAT plans, which induced higher tumor control probability reductions. A higher ∆Dmean of CTV Boost was found in 7F-H-IMRT plans despite lower ∆D(98%) and ∆D(95%). Shifts in the S-I direction exerted the largest effect on CTV and CTV Boost. Regarding OARs, shifts in R, P, and I directions contributed to increasing the received dose. The 2A-VMAT plans performed better dose sparing, but had a higher robustness in a high-dose volume of the left lung and heart. The 2A-VMAT plans decreased the max dose of LAD but exhibited lower robustness. Conclusion: The 2A-VMAT plans showed higher sensitivity to position deviation. Shifts in the S-I direction exerted the largest effect for CTV and CTV Boost.
format Online
Article
Text
id pubmed-9028731
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90287312022-04-23 Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer Ding, Zhen Zeng, Qi Kang, Kailian Xu, Meiling Xiang, Xiaoyong Liu, Chenbin Bioengineering (Basel) Article Purpose: We aim to evaluate the robustness of multi-field IMRT and VMAT plans to target motion for left-sided BC radiotherapy. Methods: The 7-field hybrid IMRT (7F-H-IMRT) and 2-arc VMAT (2A-VMAT) plans were generated for ten left-sided BC patients. Shifts of 3 mm, 5 mm, and 10 mm in six directions were introduced and the perturbed dose distributions were recalculated. The dose differences (∆D) of the original plan and perturbed plan corresponded to the plan robustness for the structure. Results: Higher ∆D(98%), ∆D(95%), and ∆D(mean) of CTV were observed in 2A-VMAT plans, which induced higher tumor control probability reductions. A higher ∆Dmean of CTV Boost was found in 7F-H-IMRT plans despite lower ∆D(98%) and ∆D(95%). Shifts in the S-I direction exerted the largest effect on CTV and CTV Boost. Regarding OARs, shifts in R, P, and I directions contributed to increasing the received dose. The 2A-VMAT plans performed better dose sparing, but had a higher robustness in a high-dose volume of the left lung and heart. The 2A-VMAT plans decreased the max dose of LAD but exhibited lower robustness. Conclusion: The 2A-VMAT plans showed higher sensitivity to position deviation. Shifts in the S-I direction exerted the largest effect for CTV and CTV Boost. MDPI 2022-03-24 /pmc/articles/PMC9028731/ /pubmed/35447691 http://dx.doi.org/10.3390/bioengineering9040131 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ding, Zhen
Zeng, Qi
Kang, Kailian
Xu, Meiling
Xiang, Xiaoyong
Liu, Chenbin
Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer
title Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer
title_full Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer
title_fullStr Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer
title_full_unstemmed Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer
title_short Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer
title_sort evaluation of plan robustness using hybrid intensity-modulated radiotherapy (imrt) and volumetric arc modulation radiotherapy (vmat) for left-sided breast cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028731/
https://www.ncbi.nlm.nih.gov/pubmed/35447691
http://dx.doi.org/10.3390/bioengineering9040131
work_keys_str_mv AT dingzhen evaluationofplanrobustnessusinghybridintensitymodulatedradiotherapyimrtandvolumetricarcmodulationradiotherapyvmatforleftsidedbreastcancer
AT zengqi evaluationofplanrobustnessusinghybridintensitymodulatedradiotherapyimrtandvolumetricarcmodulationradiotherapyvmatforleftsidedbreastcancer
AT kangkailian evaluationofplanrobustnessusinghybridintensitymodulatedradiotherapyimrtandvolumetricarcmodulationradiotherapyvmatforleftsidedbreastcancer
AT xumeiling evaluationofplanrobustnessusinghybridintensitymodulatedradiotherapyimrtandvolumetricarcmodulationradiotherapyvmatforleftsidedbreastcancer
AT xiangxiaoyong evaluationofplanrobustnessusinghybridintensitymodulatedradiotherapyimrtandvolumetricarcmodulationradiotherapyvmatforleftsidedbreastcancer
AT liuchenbin evaluationofplanrobustnessusinghybridintensitymodulatedradiotherapyimrtandvolumetricarcmodulationradiotherapyvmatforleftsidedbreastcancer